Marie L. Jones - 09 Mar 2023 Form 3 Insider Report for Silk Road Medical Inc

Role
CAO and VP, Finance
Signature
/s/ Jones, Marie L
Issuer symbol
N/A
Transactions as of
09 Mar 2023
Net transactions value
$0
Form type
3
Filing time
20 Mar 2023, 06:01:18 UTC
Next filing
21 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SILK Common Stock 45,496 09 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 6,500 $55.30 Direct F1
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 11,900 $36.55 Direct F2
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 9,225 $30.93 Direct F3
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 10,031 $6.11 Direct F4
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 8,487 $6.11 Direct F4
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 65,112 $6.11 Direct F4
holding SILK Option (right to buy) 09 Mar 2023 Common Stock 6,549 $6.11 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth of the shares subject to the option vested on April 1, 2021 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 One forty-eighth of the shares subject to the option vested on April 1, 2022 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F3 One forty-eighth of the shares subject to the option vested on April 1, 2020 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F4 All of the shares subject to the option are fully vested and exercisable as of the date hereof.